Welcome : Guest

CONTRACEPTIVES - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Contraceptives in US$ by the following Contraception Methods: Hormonal Contraceptives (Oral Contraceptives, & Other Hormonal Contraceptives), and Condoms. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 92 companies including many key and niche players such as -

Afaxys, Inc.
Agile Therapeutics, Inc.
Allergan plc
Ansell Limited
Bayer AG

Click here to request a full list of companies covered in the report...

Code: MCP-2528
Price: $4950
Companies: 92
Pages: 405
Date: January 2017
Market Data Tables: 122
 



TABLE OF CONTENTS


  CONTRACEPTIVES (Complete Report) Pages : 405   | $4950

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   Contraceptives: Transforming Birth Control, Planned Parenthood, and Women’s
  Health.....II-1
2$200
   Table 1: Contraception Methods Relied on by Women in the 15-50 Age Group Worldwide (2016E): Percentage Share Breakdown for Female Sterilization, Implants, Injectables, IUDs, Male Condoms, Male Sterilization, Oral Pill, Withdrawal Method, and Others (Vaginal Barrier Methods) (includes corresponding Graph/Chart).....II-3
Contraceptives Market: Fast Facts.....II-3
2$350
   The Vital Need to Curtail the Ballooning Global Population through Birth Control:
  The Fundamental Growth Driver.....II-5
2$200
   Effectiveness Index of Contraceptive Methods: Brief Details of Method, Efficacy
  Percentage, Benefits, Risks, and Availability.....II-7
2$200
   Unmet Contraception Needs Signals Huge Market Penetration Opportunities.....II-92$200
   Birth Control Methods and the Degree of Use in Major Regions Worldwide.....II-11
Global Population Statistics: Unfurling the Market Potential.....II-11
1$100
   Table 2: World Population by Geographic Region (2000, 2010, 2015, 2020, 2030, 2040, and 2050) (in Millions) (includes corresponding Graph/Chart).....II-12

Table 3: World Population (2015): Population and Percentage Share Breakdown by Age Group - Below 15 Years, 15-64 Years, Above 65 Years (includes corresponding Graph/Chart).....II-12
1$350
   Table 4: 15-64 Year Population as a Percentage of Total Population for Major Countries: 2015.....II-13
China & India: Two Countries with the Largest Sexually Active Population Offer
  Significant Growth Opportunities.....II-13
1$350
   Table 5: Ten Largest Populated Countries Worldwide (July 2015): Total Population (in Millions) by Age Group 0-14 Years, 15-59 Years, 60+ Years for China, India, USA, Indonesia, Brazil, Pakistan, Nigeria, Bangladesh, Russia and Mexico (includes corresponding Graph/Chart).....II-141$350
   Table 6: Ten Largest Populated Countries Worldwide (July 2015): Percentage Population by Age Group 0-14 Years, 15-59 Years, 60+ Years for China, India, USA, Indonesia, Brazil, Pakistan, Nigeria, Bangladesh, Russia and Mexico (includes corresponding Graph/Chart).....II-15
Global Market Outlook.....II-15
3$350
   Table 7: Leading Condom Companies Worldwide (2016E): Percentage Market Share of Revenues for Reckitt Benckiser, Ansell, Church & Dwight, and Others (includes corresponding Graph/Chart).....II-181$350
   Bayer’s Oral Contraceptive Pills: In the Midst of Controversies.....II-191$100
   Bayer’s “Yasmin”: A Resounding Brand Success Worldwide when Launched.....II-20
Innovative Promotion Strategies Enhance Product Appeal.....II-20
1$100
   Aging Population Adds to Manufacturer Concerns.....II-21
Manufacturers Capitalize on the Healthcare-Related Role of Contraceptives.....II-21
Teen Population: A Lucrative Demographic Segment and the New Advertising
  Target.....II-21
1$100
   Supermarkets and Internet Gain Importance in Contraceptives Retail.....II-221$100
   Condoms as a Powerful Tool against HIV/AIDS and Other STIs Witness Strong Growth in
  Demand.....II-23
1$100
   Condoms: Percentage Effectiveness of Protection against STDs.....II-24
Table 8: Number of Individuals Living with HIV Worldwide in Millions: 2000, 2005, 2010 & 2015 (includes corresponding Graph/Chart).....II-24
1$350
   Table 9: HIV Infection Statistics Worldwide (2015): Total Infected, Newly Infected, and Number of Deaths (in Millions) (includes corresponding Graph/Chart).....II-25

Table 10: Global HIV Infection Statistics by Region (2015): Total Infected, Newly Infected, and Number of Deaths (in Thousands) (includes corresponding Graph/Chart).....II-25
1$350
   Study Reveals Positive Effects of Contraceptives on HIV-Infected Women.....II-26
Contraceptive Innovations and Advancements: Spearheading Growth.....II-26
1$100
   Major Condom Innovations.....II-27
“S.T.EYE”: A Condom that Changes Color in the Presence of an STI.....II-27
1$100
   A Super Condom with the Potential to Eradicate HIV.....II-28
Other Recent Innovations in Condoms.....II-28
3$300
   Declining Prices and Increased Accessibility of Contraceptives Benefit Market
  Expansion.....II-31
1$100
   Despite Waning Popularity, Oral Contraceptives Continue to Sustain Market
  Domination.....II-32
Research Findings In Favor of and Against the Pill.....II-32
Considerably Lowers Death Rate from Ovarian Cancer.....II-32
1$100
   Helps Reduce Risk of Endometrial Cancer.....II-33
Increases Risk of Ischemic Stroke.....II-33
1$100
   Heightens the Risk of Crohn’s Disease.....II-34
Oral Contraceptives - Challenges & Strategies to Overcome Problems.....II-34
1$100
   Rising Need to Develop Contraceptives for Men Drive Robust Research &
  Development.....II-35
1$100
   Efficacy and Reduction of Side Effects: Need of the Hour for Injectable Male
  Contraceptives.....II-36
1$100
   Evolving Designs and Features in Female Condoms Drive Surging Popularity and Growing
  Adoption.....II-37
2$200
   Select Female Condom Brands Worldwide: A Comparison.....II-391$100
   FC1 and FC2 from the Female Health Company.....II-40
Female Condom from PATH.....II-40
1$100
   Other Major Developments in Female Condoms.....II-411$100
   Convenience and Cost Benefits Drive Healthy Growth in Demand for Intrauterine
  Devices.....II-42
Characteristic Features of Intrauterine Devices (IUDs).....II-42
1$100
   Key Challenges & Strategies to Overcome Problems.....II-43
Increasing Standard of Living: A Key Growth Driver.....II-43
1$100
   Table 11: Global Middle Class Population by Geographic Region: Percentage Share Breakdown for 2010, 2020P & 2030P (includes corresponding Graph/Chart).....II-44
Social Stigmas in Under Developed Countries Hamper Market Prospects.....II-44
Major Hindrances for Widespread Usages of Condoms.....II-44
1$350
   Developing Countries Continue to Drive Current and Future Market Growth.....II-45 1$100
   Table 12: Global Contraceptives Market - Geographic Regions Ranked by CAGR (Value Sales) for 2015-2022: Asia-Pacific, Rest of World, Latin America, Europe, Canada, Japan, and USA (includes corresponding Graph/Chart).....II-461$350
   Manufacturers Depend on Emerging Markets to Increase Sales Momentum.....II-471$100
   Table 13: Global Exports of Chemical and Hormonal Contraceptives by Country (2015): Percentage Breakdown of Value Exports for Germany, Netherlands, Belgium, Hungary, Ireland, India, France, Brazil, Canada, Switzerland, and Others (includes corresponding Graph/Chart).....II-48

Table 14: Global Imports of Chemical and Hormonal Contraceptives by Country (2015): Percentage Breakdown of Value Imports for USA, Belgium, Canada, Russian Federation, Mexico, Italy, Germany, Spain, UK, Brazil, and Others (includes corresponding Graph/Chart).....II-48
1$350
   Table 15: Global Exports of Sheath Contraceptives by Country (2015): Percentage Breakdown of Value Exports for Thailand, Malaysia, China, India, Hong Kong, China, Japan, UK, Hungary, Germany, Singapore, and Others (includes corresponding Graph/Chart).....II-49

Table 16: Global Imports of Sheath Contraceptives by Country (2015): Percentage Breakdown of Value Imports for China, Russian Federation, Brazil, USA, UK, Hong Kong, China, France, Italy, Germany, Singapore, and Others (includes corresponding Graph/Chart).....II-49
1$350
   Contraceptives: A Prelude.....II-50
Types of Contraception.....II-50
The Contraceptive Timeline.....II-50
1$100
   By Function.....II-51
Barrier Contraceptives.....II-51
Characteristic Features of Barrier Methods.....II-51
Hormonal Contraceptives.....II-51
Prescription Contraceptives.....II-51
1$100
   Oral Contraceptives.....II-52
Overview of Oral Contraceptives - Benefits vs. Risks.....II-52
Traditional and Modern.....II-52
1$100
   Reversible and Permanent.....II-53
Segmental Overview.....II-53
Hormonal Contraceptives.....II-53
Oral Contraceptives (OCs)/Pills.....II-53
1$100
   A Peep into the Past.....II-54
Synthetic Oral Contraceptives.....II-54
Characteristic Features of Oral Contraceptives (OCs).....II-54
1$100
   Advantages of Using OCs.....II-55
Effects of Long-Term Use of OCs.....II-55
1$100
   Use of OCs/Pills - Myths & Facts.....II-56
Factors Associated with Failure of OCs/Pills.....II-56
Health Conditions to be Addressed when Using OCs.....II-56
1$100
   Understanding Risks Associated with Use of OCs.....II-57
Cardiovascular Disease – A Major Side Effect of OCs.....II-57
Intake of OCs Result in High Blood Pressure.....II-57
1$100
   Smoking Intensifies Respiratory Problems in Pill Users.....II-58
Age Related Complications Associated with the Direct Use of OCs.....II-58
Relation Between OC and Cancer.....II-58
Depression Linked to Use of OCs.....II-58
OCs Increases Osteoporosis Risk at Later Stage.....II-58
OCs May Reduce Sex Drive.....II-58
1$100
   Effects of Pill on Childbearing Capacity.....II-59
Visiting a Doctor – Highly Recommended in Case of Warning Symptoms.....II-59
Emergency Contraception (EC) – A New Face of OCs.....II-59
Role of ECPs.....II-59
1$100
   Effectiveness of ECP.....II-60
Different Types of EC Products.....II-60
Mini Pills.....II-60
1$100
   RU486 - the French Abortion Pill.....II-61
Availability of Hormonal Contraceptives as OTC Drugs.....II-61
Other Hormonal Contraceptives.....II-61
Injectable Contraceptives.....II-61
Depo-Provera.....II-61
1$100
   Characteristic Features of Injectable Contraceptives.....II-62
Injectables - Challenges & Strategies to Overcome Problems.....II-62
1$100
   Intrauterine Devices (IUDs)/Implants.....II-63
CopperT 380A (ParaGard).....II-63
Progesterone T (or Progestasert).....II-63
Long-term Reversible Contraceptive Implants.....II-63
Norplant.....II-63
1$100
   Implanon.....II-64
Mirena.....II-64
1$100
   Characteristic Features of Implantable Contraceptives.....II-65
Challenges & Strategies to Overcome Problems.....II-65
1$100
   Spermicides.....II-66
Benefits.....II-66
Drawbacks.....II-66
Contraceptive Foam.....II-66
Delfen Contraceptive Foam.....II-66
Contraceptive Cream or Jelly.....II-66
1$100
   Encare Ovals.....II-67
Condoms.....II-67
Latex Condoms.....II-67
Non-Latex Condoms.....II-67
Skin Condoms.....II-67
1$100
   Polyurethane (PU) Condoms.....II-68
Comparison Between Polyurethane & Latex Condoms.....II-68
Myths & Facts.....II-68
1$100
   Selection & Effective Use of Condoms.....II-69
Female Condoms.....II-69
Who are the Main Users?.....II-69
1$100
   Important Regulations Governing Condom Exports.....II-70
Regulatory Procedures in Select Countries.....II-70
1$100
   Allergan Launches Combination Oral Contraceptive Capsule Taytulla.....II-71
Teva Pharmaceutical Launches Generic Oral Contraceptive RAJANITM.....II-71
Amneal Pharmaceuticals Launches Generic Contraceptive Femynor.....II-71
Tata Motors Launches Dipper Condom Brand.....II-71
Agile Therapeutics Announces Advancement of Contraceptive Pipeline.....II-71
Glenmark Pharmaceuticals Receives USFDA Tentative Approval for Lo Loestrin Fe
  Generic.....II-71
Karex Acquires TheyFit LLC, Rebrands Custom-Fit Condoms under ONE Brand.....II-71
1$100
   WomanCare Global Launches Female Condom in Zambia.....II-72
DKT international Launches Fiesta Condoms in Tanzania.....II-72
Lupin Receives FDA Approval to Market Generic Version of Warner Chilcott’s Generess
  Fe.....II-72
Lupin Launches Generic Oral Contraceptive.....II-72
Aurobindo Pharma Receives Approval to Market OC Levonorgestrel.....II-72
PSI Malawi Launches Non-Latex ‘Whisper’ Female Condom.....II-72
Pfizer Launches Sayana®Press in UK.....II-72
1$100
   Mylan Receives Approval to Market Generic Version of Bayer’s OC Yasmin.....II-73
Teva Europe Launches Extended-Regimen OC Seasonique.....II-73
Convex Corporation Launches ‘Convex’ Brand of Male Condoms.....II-73
Teva Pharmaceuticals Announces Generic for Lomedia® 24 Fe.....II-73
ONE® Condoms Launches VANISH™ Hyperthin® Condoms.....II-73
Mylan N.V. Launches Generic Version of Seasonale Tablets.....II-73
Bayer Indonesia Launches OC Based on Estradiol with Additional Benefits.....II-73
Afaxys Pharmaceuticals Launches EContra™ EZ Emergency Contraceptive.....II-73
1$100
   Glenmark Generics Launches Ashlyna™ Extended-Cycle Oral Contraceptive.....II-74
Afaxys Pharmaceuticals Launches Tarina™ Oral Contraceptive.....II-74
Mylan Launches Generic Version of Warner Chilcott's Loestrin 24 Fe®.....II-74
Lupin Pharmaceuticals Launches Nikki Oral Contraceptive Tablets.....II-74
Starpharma Receives Australian Therapeutic Goods Administration Approval for VivaGel®
  Condom.....II-74
MicroCHIPS Develops Remote Operable Contraceptive Implant.....II-74
1$100
   Teva Pharmaceutical Receives CHMP Positive Opinion for Seasonique®.....II-75
Lupin Pharmaceuticals Launches Vyfemla™ Oral Contraceptive.....II-75
Mylan Pharmaceutical Launches Generic Contraceptive Transdermal Patch Xulane.....II-75
Consilient Health Launches Lucette® Oral Contraceptive.....II-75
1$100
   Female Health Company Receives Tender Award from Brazilian Municipality.....II-76
Starpharma Holdings Signs License Agreement with Koushan Pharmed.....II-76
Female Health Company Completes Merger with Aspen Park Pharmaceuticals.....II-76
Teva Pharmaceuticals to sell Rights to 79 Pharmaceuticals.....II-76
Starpharma Holdings Signs License Agreement with Shenyang Sky and Land.....II-76
Karex Berhad Acquires UK-Based Pasante Healthcare.....II-76
Mayne Pharma Group to Acquire Generic Drug Portfolio from Teva
  Pharmaceuticals.....II-76
1$100
   Bayer Partners with USAID for Better Local Accessibility of OC Microgynon Fe.....II-77
Reckitt Benckiser Signs Agreement to Acquire Hypermarcas’ Condom Business.....II-77
Karex Bhd’s Subsidiary Signs Agreement to Buy US Condom Maker TheyFit LLC.....II-77
Bayer to Offer its Contraceptive Implant Jadelle at Half-Price in Poor
  Countries.....II-77
Karex Expands Condoms Production Capacity.....II-77
Mylan Laboratories Limited Acquires Women’s Healthcare Business from Famy
  Care.....II-77
Merck Extends Access Pricing for Contraceptive Implants.....II-77
Karex Acquires Medical-Latex (Dua) Sdn Bhd from Beiersdorf AG.....II-77
1$100
   Female Health Company Receives Tender Award through its Distributor Barrs
  Medical.....II-78
Bayer HealthCare Enters into Alliance with Afaxys Regarding IUD Marketing.....II-78
Afaxys Pharmaceuticals Enters into Partnership with Project Ruby.....II-78
Mithra Pharmaceuticals Acquires Women’s Health Portfolio from Uteron Pharma.....II-78
Gedeon Richter Enters into License and Distribution Agreement with Bayer for
  Contraceptive Patch.....II-78
Pfizer Enters into Agreement to Expand Access to Sayana® Press in Poor
  Countries.....II-78
Cupid Signs 10-year Condom Supply Agreement with Safeware & Co......II-78
1$100
   Reckitt Benckiser Group Acquires K-Y Brand from McNEIL-PPC.....II-79
TTK Protective Devices Ltd to Merge with TTK Healthcare.....II-79
1$100
   Afaxys, Inc. (USA).....II-80
Agile Therapeutics, Inc. (USA).....II-80
Allergan plc (Ireland).....II-80
1$100
   Ansell Limited (Australia).....II-81
Bayer AG (Germany).....II-81
Church & Dwight Co., Inc. (USA).....II-81
1$100
   Fuji Latex Co. Ltd. (Japan).....II-82
Janssen Pharmaceuticals, Inc. (USA).....II-82
1$100
   Karex Berhad (Malaysia).....II-83
Lupin Pharmaceuticals Inc. (USA).....II-83
Mankind Pharma Ltd. (India).....II-83
1$100
   Merck Sharp & Dohme Corp. (UK).....II-84
Mayer Laboratories, Inc. (USA).....II-84
Okamoto Industries, Inc. (Japan).....II-84
1$100
   Pfizer, Inc. (USA).....II-85
Piramal Enterprises Ltd. (India).....II-85
1$100
   Reckitt Benckiser Group Plc. (UK).....II-86
Sagami Rubber Industries Co., Ltd. (Japan).....II-86
Teva Pharmaceutical Industries Ltd. (Israel).....II-86
1$100
   Thai Nippon Rubber Industry Co., Ltd. (Thailand).....II-87
The Female Health Company/Veru Healthcare (USA).....II-87
1$100
   Table 17: World Recent Past, Current and Future Analysis for Contraceptives by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-881$350
   Table 18: World Historic Review for Contraceptives by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-891$350
   Table 19: World 14-Year Perspective for Contraceptives by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....II-901$350
   By Contraception Method:.....II-91
Table 20: World Recent Past, Current and Future Analysis for Hormonal Contraceptives by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-91
1$350
   Table 21: World Historic Review for Hormonal Contraceptives by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-921$350
   Table 22: World 14-Year Perspective for Hormonal Contraceptives by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....II-931$350
   Table 23: World Recent Past, Current and Future Analysis for Hormonal Contraceptives by Type - Oral Contraceptives and Other Hormonal Contraceptives Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-941$350
   Table 24: World Historic Review for Hormonal Contraceptives by Type - Oral Contraceptives and Other Hormonal Contraceptives Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-951$350
   Table 25: World 14-Year Perspective for Hormonal Contraceptives by Type - Percentage Breakdown of Dollar Sales for Oral Contraceptives and Other Hormonal Contraceptives Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....II-961$350
   Table 26: World Recent Past, Current and Future Analysis for Oral Contraceptives by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-971$350
   Table 27: World Historic Review for Oral Contraceptives by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-981$350
   Table 28: World 14-Year Perspective for Oral Contraceptives by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....II-991$350
   Table 29: World Recent Past, Current and Future Analysis for Other Hormonal Contraceptives by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-1001$350
   Table 30: World Historic Review for Other Hormonal Contraceptives by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-1011$350
   Table 31: World 14-Year Perspective for Other Hormonal Contraceptives by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....II-1021$350
   Table 32: World Recent Past, Current and Future Analysis for Condoms by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-1031$350
   Table 33: World Historic Review for Condoms by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-1041$350
   Table 34: World 14-Year Perspective for Condoms by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....II-1051$350
   A. Market Analysis.....III-1
Better Options and Newer Technologies in Contraception Drive Steady Market
  Growth.....III-1
Quick Facts on Contraception.....III-1
1$75
   Relentless Promotional Programs Drive Market Adoption.....III-2
Potential Revoking of Affordable Care Act Lead to Surge in Demand for LARC.....III-2
1$75
   Clinic Budgets Adversely Impacted by Heightened LARC Demand.....III-3
Inefficiency of Existing Contraception Methods Offer Immense Opportunities for
  Intrauterine Devices (IUDs).....III-3
1$75
   Measures to Overcome Lack of Awareness.....III-4
Downfall of the Earlier Versions.....III-4
1$75
   Cost Factor.....III-5
IUDs: Preferred Contraceptive among Doctors.....III-5
1$75
   FDA Issues New Guidance and Black Box Warning for Contraceptive Implants.....III-6
Development of Effective and Safe Male Contraceptives: The Saga Continues ......III-6
1$75
   Innovative and Advanced Female Contraceptives Boost Market Prospects.....III-71$75
   New Single-Size Diaphragm.....III-81$75
   Surging Popularity of Custom-Fit and Pleasure-Oriented Condoms Drive Faster
  Growth in Condom Sales.....III-9
HIV/AIDS Incidence in the US: An Important Opportunity Indicator for
  Condoms.....III-9
1$75
   Table 35: Percentage of HIV/AIDS Cases in the US, by Gender: 1993-2029 (includes corresponding Graph/Chart).....III-10
Competitive Landscape.....III-10
Domestic Players Face Tough Competition from Foreign Brands.....III-10
1$200
   Condoms Market Highly Concentrated in the US.....III-11
Table 36: Leading Condom Companies in the US (2015): Market Share Breakdown of Sales for Church and Dwight, Ansell America, Reckitt Benckiser, and Others (includes corresponding Graph/Chart).....III-11
1$200
   Table 37: Condom Sales in the US Drug Stores by Leading Players (2015): Market Share Breakdown for Church and Dwight, Ansell America, Reckitt Benckiser, and Others (includes corresponding Graph/Chart).....III-12

Table 38: Leading Condom Brands in the US (2016): Percentage Share Breakdown for Durex, Trojan & Others (includes corresponding Graph/Chart).....III-12
Trade Statistics.....III-12
Table 39: US Exports of Hormonal/Spermicidal Contraceptives by Destination Country (2015): Percentage Breakdown of Value Exports (includes corresponding Graph/Chart).....III-12
1$200
   Table 40: US Imports of Hormonal/Spermicidal Contraceptives by Country of Origin (2015): Percentage Breakdown of Value Imports (includes corresponding Graph/Chart).....III-13

Table 41: US Exports of Sheath Contraceptives by Destination Country (2015): Percentage Breakdown of Value Exports (includes corresponding Graph/Chart).....III-13

Table 42: US Imports of Sheath Contraceptives by Country of Origin (2015): Percentage Breakdown of Value Imports (includes corresponding Graph/Chart).....III-13
1$200
   Product Launches.....III-143$225
   Strategic Corporate Developments.....III-171$75
   Select Key Players.....III-184$300
   B. Market Analytics.....III-22
Table 43: US Recent Past, Current & Future Analysis for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-22
1$200
   Table 44: US Historic Review for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-231$200
   Table 45: US 14-Year Perspective for Contraceptives by Contraception Method - Percentage Breakdown of Dollar Sales for Hormonal Contraceptives (Oral and Others) and Condoms Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....III-241$200
   A. Market Analysis.....III-25
Trade Statistics.....III-25
Table 46: Canadian Exports of Hormonal/ Spermicidal Contraceptives by Destination Country (2015): Percentage Breakdown of Value Exports (includes corresponding Graph/Chart).....III-25

Table 47: Canadian Imports of Hormonal/ Spermicidal Contraceptives by Country of Origin (2015): Percentage Breakdown of Value Imports (includes corresponding Graph/Chart).....III-25
1$200
   Table 48: Canadian Exports of Sheath Contraceptives by Destination Country (2015): Percentage Breakdown of Value Exports (includes corresponding Graph/Chart).....III-26

Table 49: Canadian Imports of Sheath Contraceptives by Country of Origin (2015): Percentage Breakdown of Value Imports (includes corresponding Graph/Chart).....III-26
1$200
   B. Market Analytics.....III-27
Table 50: Canadian Recent Past, Current & Future Analysis for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-27
1$200
   Table 51: Canadian Historic Review for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-281$200
   Table 52: Canadian 14-Year Perspective for Contraceptives by Contraception Method - Percentage Breakdown of Dollar Sales for Hormonal Contraceptives (Oral and Others) and Condoms Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....III-291$200
   A. Market Analysis.....III-30
Growing Overseas Demand Offer Major Boost to Japanese Condoms.....III-30
Local Manufacturers Expand Capacity to Meet Growing Demand.....III-30
1$75
   Major Condom Brands in Japan.....III-31
Crown and Beyond Seven.....III-31
Kimono Condoms.....III-31
Impact of Legalization of Oral Contraceptives.....III-31
1$75
   Select Key Players.....III-321$75
   B. Market Analytics.....III-33
Table 53: Japanese Recent Past, Current & Future Analysis for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-33
1$200
   Table 54: Japanese Historic Review for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-341$200
   Table 55: Japanese 14-Year Perspective for Contraceptives by Contraception Method - Percentage Breakdown of Dollar Sales for Hormonal Contraceptives (Oral and Others) and Condoms Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....III-351$200
   Market Analysis.....III-36
Market Analysis.....III-36
1$75
   Table 56: European Recent Past, Current & Future Analysis for Contraceptives by Geographic Region/Country - France, Germany, Italy, UK, Spain, Russia, and Rest of European Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-371$200
   Table 57: European Historic Review for Contraceptives by Geographic Region/Country - France, Germany, Italy, UK, Spain, Russia, and Rest of European Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-381$200
   Table 58: European 14-Year Perspective for Contraceptives by Geographic Region/Country - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of European Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....III-391$200
   Table 59: European Recent Past, Current & Future Analysis for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-401$200
   Table 60: European Historic Review for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-411$200
   Table 61: European 14-Year Perspective for Contraceptives by Contraception Method - Percentage Breakdown of Dollar Sales for Hormonal Contraceptives (Oral and Others) and Condoms Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....III-421$200
   Market Analysis.....III-43
Table 62: French Recent Past, Current & Future Analysis for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-43
1$200
   Table 63: French Historic Review for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-441$200
   Table 64: French 14-Year Perspective for Contraceptives by Contraception Method - Percentage Breakdown of Dollar Sales for Hormonal Contraceptives (Oral and Others) and Condoms Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....III-451$200
   A. Market Analysis.....III-46
Strategic Corporate Development.....III-46
Bayer AG: A Major Germany-based Company.....III-46
1$75
   B. Market Analytics.....III-47
Table 65: German Recent Past, Current & Future Analysis for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-47
1$200
   Table 66: German Historic Review for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-481$200
   Table 67: German 14-Year Perspective for Contraceptives by Contraception Method - Percentage Breakdown of Dollar Sales for Hormonal Contraceptives (Oral and Others) and Condoms Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....III-491$200
   A. Market Analysis.....III-50
Product Launch.....III-50
1$75
   B. Market Analytics.....III-51
Table 68: Italian Recent Past, Current & Future Analysis for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-51
1$200
   Table 69: Italian Historic Review for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-521$200
   Table 70: Italian 14-Year Perspective for Contraceptives by Contraception Method - Percentage Breakdown of Dollar Sales for Hormonal Contraceptives (Oral and Others) and Condoms Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....III-531$200
   A. Market Analysis.....III-54
Contraceptives: A Mature Market.....III-54
Table 71: Condom Usage in the UK (2015): Breakdown of Usage Rate by Gender and Age (includes corresponding Graph/Chart).....III-54
1$200
   Durex: The Dominant Condom Brand in the UK.....III-55
Product Launches.....III-55
Strategic Corporate Developments.....III-55
1$75
   Select Key Players.....III-561$75
   B. Market Analytics.....III-57
Table 72: The UK Recent Past, Current & Future Analysis for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-57
1$200
   Table 73: The UK Historic Review for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-581$200
   Table 74: The UK 14-Year Perspective for Contraceptives by Contraception Method - Percentage Breakdown of Dollar Sales for Hormonal Contraceptives (Oral and Others) and Condoms Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....III-591$200
   Market Analysis.....III-60
Table 75: Spanish Recent Past, Current & Future Analysis for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-60
1$200
   Table 76: Spanish Historic Review for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-611$200
   Table 77: Spanish 14-Year Perspective for Contraceptives by Contraception Method - Percentage Breakdown of Dollar Sales for Hormonal Contraceptives (Oral and Others) and Condoms Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....III-621$200
   A. Market Analysis.....III-63
Lower Prices in Comparison to Oral Contraceptives Drive Faster Growth in Demand for
  Condoms.....III-63
1$75
   B. Market Analytics.....III-64
Table 78: Russian Recent Past, Current & Future Analysis for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-64
1$200
   Table 79: Russian Historic Review for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-651$200
   Table 80: Russian 14-Year Perspective for Contraceptives by Contraception Method - Percentage Breakdown of Dollar Sales for Hormonal Contraceptives (Oral and Others) and Condoms Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....III-661$200
   A. Market Analysis.....III-67
Strategic Corporate Developments.....III-67
Allergan plc – A Major Ireland-Based Company.....III-67
1$75
   B. Market Analytics.....III-68
Table 81: Rest of European Recent Past, Current & Future Analysis for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-68
1$200
   Table 82: Rest of European Historic Review for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-691$200
   Table 83: Rest of European 14-Year Perspective for Contraceptives by Contraception Method - Percentage Breakdown of Dollar Sales for Hormonal Contraceptives (Oral and Others) and Condoms Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....III-701$200
   A. Market Analysis.....III-71
Large Populations in Asian Countries Turbo Charge Global Market Growth.....III-71
China & India: Two Countries with the Largest Young Population Offer Significant
  Growth Opportunities.....III-71
1$75
   Table 84: Ten Largest Populated Countries Worldwide (July 2015): Total Population (in Millions) by Age Group 0-14 Years, 15-59 Years, 60+ Years for China, India, USA, Indonesia, Brazil, Pakistan, Nigeria, Bangladesh, Russia and Mexico (includes corresponding Graph/Chart).....III-721$200
   Table 85: Ten Largest Populated Countries Worldwide (July 2015): Percentage Population by Age Group 0-14 Years, 15-59 Years, 60+ Years for China, India, USA, Indonesia, Brazil, Pakistan, Nigeria, Bangladesh, Russia and Mexico (includes corresponding Graph/Chart).....III-731$200
   Rising HIV/AIDS Prevalence Drive Strong Demand for Condoms.....III-74
Table 86: HIV/AIDS Stats in Asia (2014) (includes corresponding Graph/Chart).....III-74
1$200
   Table 87: Top Twelve Countries in Asia-Pacific with the Highest HIV Incidence (2012) (includes corresponding Graph/Chart).....III-751$200
   B. Market Analytics.....III-76
Table 88: Asia-Pacific Recent Past, Current & Future Analysis for Contraceptives by Geographic Region/Country - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-76
1$200
   Table 89: Asia-Pacific Historic Review for Contraceptives by Geographic Region/Country - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-771$200
   Table 90: Asia-Pacific 14-Year Perspective for Contraceptives by Geographic Region/Country - Percentage Breakdown of Dollar Sales for China, India, and Rest of Asia-Pacific Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....III-781$200
   Table 91: Asia-Pacific Recent Past, Current & Future Analysis for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-791$200
   Table 92: Asia-Pacific Historic Review for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-801$200
   Table 93: Asia-Pacific 14-Year Perspective for Contraceptives by Contraception Method - Percentage Breakdown of Dollar Sales for Hormonal Contraceptives (Oral and Others) and Condoms Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....III-811$200
   A. Market Analysis.....III-82
End of One-Child Policy: Only a Temporary Setback.....III-82
1$75
   Table 94: Total Population (Millions) in China: 1950, 2015, and 2030 (includes corresponding Graph/Chart).....III-83
Key Trends in the Chinese Condoms Market.....III-83
Imported Condoms: A Big Hit in China.....III-83
Fight against HIV to Augur Well for Condoms Market.....III-83
1$200
   Chinese Condom Makers Eyeing Smaller Cities to Spruce up Sales.....III-84
Counterfeit Products: A Bane for the Chinese Condoms Market.....III-84
1$75
   Trade Statistics.....III-85
Table 95: Chinese Import and Export Data of Hormonal Contraceptives (2016, 2015 & 2014): Import/Export Volume (Kg) and Import/Export Value (US$ Million) (includes corresponding Graph/Chart).....III-85
1$200
   Table 96: Chinese Import and Export Data of Sheath Contraceptives (2016, 2015 & 2014): Import/Export Volume (Kg) and Import /Export Value (US$ Million) (includes corresponding Graph/Chart).....III-86
Strategic Corporate Development.....III-86
1$200
   B. Market Analytics.....III-87
Table 97: Chinese Recent Past, Current & Future Analysis for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-87
1$200
   Table 98: Chinese Historic Review for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-881$200
   Table 99: Chinese 14-Year Perspective for Contraceptives by Contraception Method - Percentage Breakdown of Dollar Sales for Hormonal Contraceptives (Oral and Others) and Condoms Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....III-891$200
   A. Market Analysis.....III-90
The Urgent Need for Population Control Drives Market Demand.....III-90
Table 100: Total Population (Millions) in India: 1950, 2015, and 2030 (includes corresponding Graph/Chart).....III-90
1$200
   Innovative Media Campaigns Boost Condom Sales.....III-91
Social Stigma Continues to Hamper Market Growth, Despite Improvements in
  Retailing.....III-91
1$75
   Indiscreet Usage of Emergency Contraceptive (EC) on the Rise.....III-92
Table 101: Leading Condom Brands in India (2016): Percentage Share Breakdown for Durex, Kama Sutra, Manforce, Moods & Skore (includes corresponding Graph/Chart).....III-92
1$200
   Product Launches.....III-93
Strategic Corporate Developments.....III-93
Select Key Players.....III-93
3$225
   B. Market Analytics.....III-96
Table 102: Indian Recent Past, Current & Future Analysis for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-96
1$200
   Table 103: Indian Historic Review for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-971$200
   Table 104: Indian 14-Year Perspective for Contraceptives by Contraception Method - Percentage Breakdown of Dollar Sales for Hormonal Contraceptives (Oral and Others) and Condoms Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....III-981$200
   A. Market Analysis.....III-99
Thailand Emerge as a Leading Global Condoms Exporter.....III-99
1$75
   Product Launches.....III-100
Strategic Corporate Developments.....III-100
1$75
   Select Key Players.....III-1012$150
   B. Market Analytics.....III-103
Table 105: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-103
1$200
   Table 106: Rest of Asia-Pacific Historic Review for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-1041$200
   Table 107: Rest of Asia-Pacific 14-Year Perspective for Contraceptives by Contraception Method - Percentage Breakdown of Dollar Sales for Hormonal Contraceptives (Oral and Others) and Condoms Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....III-1051$200
   A. Market Analysis.....III-106
Strategic Corporate Development.....III-106
1$75
   B. Market Analytics.....III-107
Table 108: Latin American Recent Past, Current & Future Analysis for Contraceptives by Geographic Region/Country - Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-107
1$200
   Table 109: Latin American Historic Review for Contraceptives by Geographic Region/Country - Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-1081$200
   Table 110: Latin American 14-Year Perspective for Contraceptives by Geographic Region/Country - Percentage Breakdown of Dollar Sales for Brazil, and Rest of Latin America Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....III-1091$200
   Table 111: Latin American Recent Past, Current & Future Analysis for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-1101$200
   Table 112: Latin American Historic Review for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-1111$200
   Table 113: Latin American 14-Year Perspective for Contraceptives by Contraception Method - Percentage Breakdown of Dollar Sales for Hormonal Contraceptives (Oral and Others) and Condoms Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....III-1121$200
   A. Market Analysis.....III-113
High National Regulation Standards.....III-113
1$75
   B. Market Analytics.....III-114
Table 114: Brazilian Recent Past, Current & Future Analysis for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-114
1$200
   Table 115: Brazilian Historic Review for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-1151$200
   Table 116: Brazilian 14-Year Perspective for Contraceptives by Contraception Method - Percentage Breakdown of Dollar Sales for Hormonal Contraceptives (Oral and Others) and Condoms Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....III-1161$200
   Market Analysis.....III-117
Table 117: Rest of Latin American Recent Past, Current & Future Analysis for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-117
1$200
   Table 118: Rest of Latin American Historic Review for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-1181$200
   Table 119: Rest of Latin American 14-Year Perspective for Contraceptives by Contraception Method - Percentage Breakdown of Dollar Sales for Hormonal Contraceptives (Oral and Others) and Condoms Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....III-1191$200
   A. Market Analysis.....III-120
Underdeveloped African Markets Present Huge Market Potential.....III-120
1$75
   South Africa: Government Programs Drive Popularity of Female Condoms.....III-121
Product Launches.....III-121
1$75
   Strategic Corporate Developments.....III-1221$75
   Teva Pharmaceutical Industries Limited: A Major Israel-Based Company.....III-1231$75
   B. Market Analytics.....III-124
Table 120: Rest of World Recent Past, Current & Future Analysis for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-124
1$200
   Table 121: Rest of World Historic Review for Contraceptives by Contraception Method - Hormonal Contraceptives (Oral and Others) and Condoms Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-1251$200
   Table 122: Rest of World 14-Year Perspective for Contraceptives by Contraception Method - Percentage Breakdown of Dollar Sales for Hormonal Contraceptives (Oral and Others) and Condoms Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....III-1261$200
  
Total Companies Profiled: 125 (including Divisions/Subsidiaries - 142)

Region/Country Players

The United States 30 Canada 2 Japan 3 Europe 31 France 3 Germany 9 The United Kingdom 5 Italy 1 Rest of Europe 13 Asia-Pacific (Excluding Japan) 50 Latin America 23 Africa 3
Click here to request a full table of contents and more details on this project.